Geneva/ New York, 16 June 2020 – Lower-income countries across the world will now be able to access life-saving pneumococcal conjugate vaccines, which protect against the leading cause of pneumonia, for US$ 2 per dose, thanks to a new supply agreement between UNICEF, Gavi’s procurement partner, and the Serum Institute of India (SII). The new price represents a 43 per …

2020年6月18日 · The price of a major pneumonia vaccine has dropped dramatically, from $3.50 to $2 per dose, in low-income countries thanks to a new supply agreement between UNICEF and the Serum Institute of India, Gavi, the Vaccine Alliance, announced Tuesday. The Serum Institute of India, a biotech company that manufactures vaccines, will provide 10 million doses of …

Geneva/ New York, 16 June 2020 – Lower-income countries across the world will now be able to access life-saving pneumococcal conjugate vaccines, which protect against the leading cause of pneumonia, for US$ 2 per dose, thanks to a new supply agreement between UNICEF, Gavi’s procurement partner, and the Serum Institute of India (SII).

2020年9月20日 · Its previous $3.50 price point thwarted many children in poverty-stricken countries from accessing this life-saving vaccine. However, a new supply agreement between the United Nations Children’s Fund (UNICEF) and the Serum Institute of India has dramatically dropped the pneumonia vaccine price by 43%, making the PCV vaccine cost $2 per dose.

2025年1月31日 · Pneumococcal Conjugate Vaccine (PCV) price data See awarded prices paid per dose of PCV. About This table provide an overview of prices contracted with suppliers by UNICEF per vaccine. Updated on 31 January 2025.

Seattle, Washington, June 18, 2020 —PATH welcomes Gavi, the Vaccine Alliance’s recent announcement of a new supply agreement awarded to Serum Institute of India, Pvt. Ltd. (SIIPL) under the Advance Market Commitment (AMC) for its World Health Organization prequalified pneumococcal conjugate vaccine (PCV), PNEUMOSIL®. The news marks an important …

The Serum Institute vaccine is designed to protect children in low-resource countries from the kinds of pneumococcus that cause the most disease where they live at less than two-thirds of the usual cost.

2019年12月19日 · Prequalification allows PNEUMOSIL® to be procured by United Nations agencies and Gavi, the Vaccine Alliance. This news marks an important milestone toward alleviating one of the biggest barriers to sustainable access to pneumococcal conjugate vaccine that countries face-price.

2020 06 29 PCV Price web update - clean.xlsx

Geneva, 16 June 2020 – Lower-income countries across the world will now be able to access lifesaving pneumococcal conjugate vaccines, which protect against the leading cause of pneumonia, for US$ 2 per dose, thanks to a new supply agreement between UNICEF, Gavi’s procurement partner, and the Serum Institute of India (SII).

This table provide an overview of prices contracted with suppliers by UNICEF per vaccine.

***Lower price subject to manufacture confirmation, and applicable to specific countries. Last updated 31st January, 2025